FTC: give consumers health info control; Health & Fitness wearables (PRVR–6/2 –6/6/2014)

This week on Pharma Research VIDEO Report: 1) According to The Economic Times, due to new FDA rules India’s $15 billion-a-year global pharmaceutical exporting businesses are shifting their focus on generic drugs being shipped to the U.S. 2) The Federal Trade Commission recommended to Congress the passage of legislation to give consumers added control over their personal health information. 3) Cityzen Sciences Managing Director International Gilbert Reveillon discusses his company’s health & fitness wearable tech shirt.

Link to this video in the Cloud: https://cloud.real.com/s/Lqn5PR

Comparing Observational MR; Proposed Part D changes; FDA generic Rx initiative; HIMSS reports on HC mobile implementation vs. usage; MDLinx verifying European MDs; Novartis expands clinical data transparency; SAP testing “Medical Insights” cancer patient assistance (PMRVR–3/4/14)

In this Pharma Market Research VIDEO Report:  1) GRACE, an 11-item checklist of data and methods, allows testing of baseline quality criteria for observational research.  2) The CMS is proposing changes to Medicare Part D. The big picture change calls for stopping automatic Medicare coverage of two drug classes; the underlying consideration in the plan could lead to federal government price negotiations with pharmacos (expressly forbidden in legislation that established Part D).  3) The FDA launches a $20 million initiative to test generic drug production, which represents 80% of Rx drugs. India, wiht its $15 billion in annual generic drug production, is a primary focus but China is also in the crosshairs. 4) HIMSS mobile research study investigates its implementation and use by healthcare providers.  5) GfK reports an upsurge in 2013 in purchase of mobile-connected medical devices in top European countries.  6) MDLinx is launching its physician verification service in Europe.  7) The Kaiser Family Foundation reports users of the ACA website were more price-oriented than physician-focused.  8) Novartis says it has extended its pharmaco leadership in clinical trial data transparency.  9) SAP is testing “Medical Insights,” a capability that aids cancer patients by pulling relevant data from many cancer data sources, runs advanced analytics and delivers customized results in real time.